tanzania times : Latest News and In-depth Analysis
Contact Us
Search

Sports

tanzania times : Latest News and In-depth Analysis
HomeSports
Sports

Mar 18, 2025

Optoma Introduces the Ultimate Display Management Solution

TAIPEI,March 18,2025-- The widely acclaimed Optoma Management Suite (OMS),an innovative display device management system highly praised by IT administrators,has undergone a comprehensive upgrade in 20
Sports

China Merchants Commercial REIT Reports Total Revenue of RMB529 Million in 2024; Occupancy Rate at Garden City Shopping Centre in Shenzhen Surges Significantly; Overall Operational Performance Continues to Optimize

HONG KONG,March 18,2025-- China Merchants Commercial Real Estate Investment Trust ("CMC REIT" or "the Trust",HKEX stock code:1503),announced its annual results for the year ended 3

Mar 18, 2025
Sports

LONGi's SSA Exhibition Concludes Successfully with a Surge of Orders

XI\'AN,China,March 18,2025-- From March 11th to 13th,the largest photovoltaic exhibition in the Netherlands,Solar Solutions Amsterdam (SSA),was grandly held in Amsterdam. As a globally leading solar

Mar 18, 2025
Sports

UniCom Showcases Digital Innovations at MWC 2025

Mar 10, 2025

All News

Sports

ATxEnterprise 2025 Celebrates Five Years of Powering Enterprise Technology, Cybersecurity, and Digital Transformation

SINGAPORE,Feb. 14,2025-- ATxEnterprise (ATxE) 2025,a flagship event of Asia Tech x Singapore (ATxSG),returns for its fifth year,providing a strategic platform for enterprises,governments,and technolo

Feb 17, 2025

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003

SUZHOU,China,Feb. 13,2025-- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 bi

Feb 14, 2025

Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.

Feb 14, 2025

Study Results Abstracts From Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) At 2025 ASCO Genitourinary Cancers Symposium

CHENGDU,China,Feb. 13,2025-- At the American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium 2025,to be held in San Francisco,USA,from Feb. 13-15,2025,Sichuan Kelun-Biotech Bi

Feb 14, 2025
Sports

Antengene Announces XPOVIO® Approved for Public Health Insurance Coverage in Taiwan Market, Benefiting More Patients with R/R MM in the Region

XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).

Feb 14, 2025
Sports

Mega Matrix Inc. Announced that the Urban Romance Micro Drama "A flash Marriage With The Billionaire Tycoon" Premiered on FlexTV

SINGAPORE,Feb. 13,2025-- Mega Matrix Inc. (NYSE American: MPU)\'s globally leading short series streaming platform,FlexTV,has launched a romantic miniseries exploring love,responsibility,and redempti

Feb 14, 2025
1 ... 64 65 66 67 68 69 70 ... 107